Supplementary Figure 4 from Resistance to Selective FGFR Inhibitors in <i>FGFR-</i>Driven Urothelial Cancer

<p>Expression of FGFR3:TACC3 was homogeneous across Ba/F3 cell lines.</p>

Na minha lista:

Detalhes bibliográficos
Autor principal:	Francesco Facchinetti (16827090) (author)
Outros Autores:	Antoine Hollebecque (15010338) (author), Floriane Braye (16827093) (author), Damien Vasseur (16827096) (author), Yoann Pradat (15352227) (author), Rastislav Bahleda (16617234) (author), Cédric Pobel (16617263) (author), Ludovic Bigot (16617254) (author), Olivier Déas (16827099) (author), Juan David Florez Arango (16827102) (author), Giorgia Guaitoli (16827105) (author), Hayato Mizuta (16827108) (author), David Combarel (16827111) (author), Lambros Tselikas (15019536) (author), Stefan Michiels (9081965) (author), Sergey I. Nikolaev (15061686) (author), Jean-Yves Scoazec (15036392) (author), Santiago Ponce-Aix (16827114) (author), Benjamin Besse (15061674) (author), Ken A. Olaussen (16827117) (author), Yohann Loriot (15123021) (author), Luc Friboulet (15025943) (author)
Publicado em:	2025
Assuntos:	Cancer Therapeutic Research and Development Drug Resistance Clinical drug resistance Reversal of drug resistance Drug Targets Protein kinase & phosphatase drug targets Genitourinary Cancers Bladder cancer
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados